TOKYO, March 31 (Reuters) - Fujifilm Holdings Corp 4901.T
said on Wednesday that Shigetaka Komori, who oversaw the
company's transition from film business to healthcare, would
step down as chairman and chief executive in June.
Komori, 81, will take a new role as chief adviser while
Teiichi Goto becomes CEO and Kenji Sukeno the chairman. The
transitions are subject to approval by shareholders, Fujifilm
said in a release.
Komori is credited with helping Fujifilm transform its
business and survive the collapse of the film industry that
drove its main rival Eastman Kodak Co into bankruptcy.
Fujifilm's push into healthcare has become all the more
apparent amid the pandemic, as its antiviral drug Avigan is
being studied as a COVID-19 treatment.
The company has invested heavily in Europe and the United
States to expand factories involved in making ingredients for
vaccines and drugs. urn:newsml:reuters.com:*:nL1N2KR02F urn:newsml:reuters.com:*:nL4N2DN06M
Komori joined Fuji Photo Film Co in 1963 and was appointed
CEO in 2003, according to the company.
(Reporting by Rocky Swift; Editing by Shailesh Kuber)
((rocky.swift@thomsonreuters.com;))